Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: A feasibility study
Cardiovascular and Interventional Radiology Aug 11, 2017
Patelli G, et al. – A feasibility study was conducted to evaluate the utility and safety of transperineal laser ablation (TPLA) for treating benign prostatic hyperplasia (BPH). It was concluded that TPLA is feasible and safe in the treatment of BPH, providing significant clinical results at 3 months.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
